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Renal Transplantation in Baboons Under FK 506 
O. Imventarza, S. Todo, G. Eiras, Y. Ueda, H. Furukawa, Y.M. Wu, Y. Zhu, A. Oks, J. Demetris, 
and T.E. Starzl 
B EFORE embarking on a clinical trial of FK 506. the 
effectiveness and safety of this agent were examined 
with exhaustive animal studies in rats. dogs. and subhu-
man primates. Reponed here are the results of baboon 
experiments. with renal transplantation and correlation 
with parallel in vitro mixed lymphocyte reaction (MLR) 
determinations. Part of this work was previously reponed 
elsewhere. 1.2 
MATERIALS AND METHODS 
Unrelated female baboons. weighing 8 to 14 kg. were used. Renal 
iransplantation was perfonned intraabdominally. Ureteroneocys-
tostomy was made following removal of the native kidneys of the 
recipients. Lymphocyte sensitivity to FK 506 in rats. dogs. and 
baboons was determined using the one-way MLR. which IS 
standard in our laboratories. ~ 
RESULTS 
Dose-Dependent Study 
Stanmg on day 4. the baboons were given oral FK 506 in 
doses of 0 mglkgd In = 41. 2 mg/kgJd (n = 2).6 mgkgd In 
= 41. 12 mgkgtd (n = 51. and 18 mglkgld (n = 51. In 
addition. FK 506 was given to animals intramuscularly for 
the first 3 days. The oral medication was continued for 90 
days. Using 90 da\S as a ceiling for calculation. th~ mean 
animal sunl\ al \10 a~ 9.2 = 4.0 f SOl days at 0 mg.kg. d. 1 n = 
2.0 da~s at 2 mg k.g. d. 29.5 = 21.2 da~Ds at 6 mglkg d. 70.8 
= :-.6 days at I: mgkgd. and 74.6 = 28.9 da\\ at 18 
mg kg.d f Fig I). civ~ animab receiving 12 or 18 mg. "g FK 
506 li\fd for mort! than 90 days. 
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FK S(lf> trcatmt!n!. while tho,e gl\..:n FK S(lf> ,hoI' cd 
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Fig 1. Mean su'\wal 01 baboons treated With different doses of 
FK 506 after rena transplantation 
dose-dependent maintenance of graft function. Histo-
pathologic analyses of renal allografts in baboons who died 
within 90 days showed moderate to severe rejection. with 
the exception of two animals who died of pyelonephritis 
and unknown causes .. 
Hepatic Fundion and Blood Glucose 
Hepatic function and blood glucose levels were normal 
and not significantly different in untreated and treated 
animals (Table I). 
FK Blood levels 
Blood levels were determined by an enzyme immunoassay 
using monoclonal antibody to FK 506. J Although the doses 
given to animals varied between groups. there was no 
statistical difference in the blood levels (Table I). 
Histopathology of Extrarenal Organs 
Specimens were collected at autopsy from 15 animals that 
died within 90 days. In five other baboons. a bior~~ of the 
graft was performed at 90 days: these biopsies sh,w'ed no 
imponant abnormalitIes in the Ii\ t!r and pancreas that were 
suggestive of drug side effect. Tht!re was no anent IS in any 
organs from any of the animal~ except for fibrinolJ change 
of a single vessel in the appendi\ and the stomach. 
Long·term Observations After Discontinuing FK Treatment 
Of five animals who li\ ed for more than 90 ":.1\ s after 
'tl)PPlng oral FK Ircatmen!. four IubDcquentl~ ":c\elopcd 
allograft rCJeCtlllO. :\ KD·da~ cour,c of inlrgmrDcu:Kl~ FK ~Eltt 
Ircatment. 2 mg."!:! d. r..:\..:r,ed rC.leClillO 10 1\\,' IJf thKK:D~ 
fllur ammal". but \.la, nIH etf,,:cl!\C \\lIh the 11Ih,," 1\\0 .. -\11 
four anima'" dl~d e\ ~ntuall~ of Llrgan reKle~tllln The tifth 
aOlma!. II hleh ne\ cr h<.ld a r":Jcctllln. 1\ a, "I:: ~g at ~Kg~ 
dav,. in a health\ 't.lte ,JOd <It J tlm~ \thcn r~nK!K iunetll)n 
II<.1S normal. Therc \loa, nll hl'tlllelgl': Jbnllrm.! .. I~ in t~lD 
"fdnKK:~ Ilr other organ, . 
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Table 1. Postoperative SGOT. SGPT. Total Bilirubin. Blood Glucose. and FK 506 levels In Baboons In Groups 1 to 5 
Dose 01 
Oral FK 506 SGOT 
Group Imgkgd) No. (UI) 
0 4 49.5:: 49.5 
2 2 2 38.7:: 19.7 
3 6 4 45.0:: 20.3 
4 12 5 51.0:: 28.8 
5 18 5 49.4:: 30.9 
Sensitivity of Baboon Lymphocytes to FK 506 
In the early stage of the baboon experiments, immunosup-
pression by FK 506 was unsuccessful. even when much 
higher doses than those given in earlier canine ex-
periments" were used. From this finding arose the question 
as to whether there was a difference in the sensitivity of 
lymphocytes to this agent between species. The results 
with MLRs under different concentrations in the medium 
show that cells from the baboon need a dose of FK 506 10 
times higher than that needed by dogs or humans to 
suppress the MLR reaction (Table 2). This information is 
being reponed separately. 2 
DISCUSSION 
Our greatest concern was the potential toxicity of FK 506. 
which has previously been reponed to cause diabetes. 
Table 2. Species Differences In the Sensitivity of lymphocytes 
to FK 506 
FK 506 ConcenlratJOn OptIOnal 
to Achreve a SO", Oral 
Inhlbrtoon 01 MLR Dose 
Ing-ml) (mg kg d) 
Aat 0.33 :: 0.2 1·2 
Dog 0.59 :: 0.58 1·' 5 
Baboon 3.85:: 2.0 '2·18 
Human 0.29:: 0.2 0.15·03 
Serum Total BlOod Plasma 
SGPT BilIrubin Glucose FK S06 
(U I) (mgdl) (mgdl) 1"9 mI) 
12.0:: 13.7 0.7:: 0.4 103 :: 4 
37.4 :: 40.5 0.5:: 0.5 87:: 78 1.26:: 1.20 
25.4 :: '7.6 0.4:: 0.4 104 :: 20 4.27:: 2.87 
29.7:: 28.6 0.2:: 0.2 86:: 76 3.26 :: 1.85 
36.4:: 64.6 0.4:: 0.8 102 :: 43 5.24:: 5.00 
lassitude, arteritis, and other serious problems in 
baboons. ~ However, none of these major toxicities was 
seen in our baboon experiments, even when the FK 506 
dL'se given daily over a 3-month period was 10 times higher 
than the dose causing lethal emaciation in dogs. 4 
The unexpectedly high dose required for prevention of 
allograft rejection in baboons correlated with the relative 
resistance of baboon lymphocytes to this drug. as shown 
with MLR testing. In addition, the in vitro experiments 
showed that human lymphocyte sensitivity was closer to 
that of dogs, a finding that was confirmed in our clinical 
experience.'" Therefore, FK 506 was a safe and effective 
immun~Dsuppressive agent for renal transplantation in ba-
boons. These experiments were performed in preparation 
for a clinical trial. 
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